Senior Vice President, General Counsel and Secretary · Caris Life Sciences, Inc. (CAI)

J. Russel Denton

FY2025 is the first fiscal year CompBrief holds for J. Russel Denton as a named executive officer of Caris Life Sciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$5,354,614

Compensation figures as of the proxy filed April 23, 2026 (DEF 14A).

J. Russel Denton compensation by year

Caris Life Sciences Summary Compensation Table · the one fiscal year held
In US dollars, as Caris Life Sciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$458,951
Bonus$263,897
Stock awards$2,085,741
Option awards$2,532,025
Non-equity incentive$0
Pension and deferred compensation$0
All other$14,000
Total$5,354,614

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Caris Life Sciences, Inc. DEF 14A filed April 23, 2026, accession 0002019410-26-000032, and prior-year filings. Open the filing on EDGAR.

Caris Life Sciences’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
David Dean HalbertFounder, Chairman and Chief Executive Officer$20,350,571
David SpetzlerPresident$11,583,227
J. Russel Denton · this pageSenior Vice President, General Counsel and Secretary$5,354,614

The full Caris Life Sciences compensation record

free company brief

This page is one person within Caris Life Sciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Caris Life Sciences's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Caris Life Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy